Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2292

TDMS Study 05063-01 Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                           PHENYLBUTAZONE


NTP Experiment-Test: 05063-01                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/08/94
Route: GAVAGE                                                                                                     Time: 19:05:34




       Facility:  TSI Mason Research

       Chemical CAS #:  50-33-9

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05063-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           PHENYLBUTAZONE                                      Date: 09/08/94  
Route: GAVAGE                                                                                                     Time: 19:05:34  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      0.05G/KG     0.1 G/KG                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50                                                  
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                14            9           14                                                  
    Natural Death                                      5            5           14                                                  
    Accident                                                        1                                                               
  Survivors                                                                                                                         
    Terminal Sacrifice                                30           35           21                                                  
    Natural Death                                                                1                                                  
    Terminal Sacrifice                                 1                                                                            
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (48)         (5)          (49)                                                
      Depletion Lymphoid                                                         1 (2%)                                             
      Parasite Metazoan                                1 (2%)       1 (20%)      1 (2%)                                             
   Intestine Large, Colon                             (49)         (7)          (49)                                                
      Angiectasis                                                                1 (2%)                                             
      Parasite Metazoan                                9 (18%)                   6 (12%)                                            
      Mucosa, Fibrosis                                                           1 (2%)                                             
   Intestine Large, Rectum                            (48)         (6)          (48)                                                
      Metaplasia, Focal, Squamous                                                1 (2%)                                             
      Parasite Metazoan                                1 (2%)                    1 (2%)                                             
   Intestine Small, Duodenum                          (50)         (9)          (50)                                                
      Abscess, Chronic                                                           1 (2%)                                             
      Inflammation, Chronic Active, Necrotizing                                  2 (4%)                                             
      Epithelium, Hyperplasia                                                    1 (2%)                                             
      Muscularis, Inflammation, Acute                                            1 (2%)                                             
      Muscularis, Mineralization                                                 1 (2%)                                             
      Serosa, Fibrosis                                                           1 (2%)                                             
      Serosa, Inflammation, Chronic                                              1 (2%)                                             
   Intestine Small, Ileum                             (49)         (8)          (50)                                                
      Lymphoid Nodule, Depletion Cellular                                        1 (2%)                                             
   Intestine Small, Jejunum                           (49)         (7)          (49)                                                
      Hemorrhage                                       1 (2%)                                                                       
      Inflammation, Chronic Active, Necrotizing                                  1 (2%)                                             
      Ulcer                                                                      1 (2%)                                             
      Muscularis, Inflammation, Acute                                            1 (2%)                                             
      Muscularis, Mineralization                                                 1 (2%)                                             
   Liver                                              (50)         (27)         (50)                                                
      Angiectasis                                      1 (2%)       2 (7%)       1 (2%)                                             
      Basophilic Focus                                35 (70%)     14 (52%)     31 (62%)                                            
      Clear Cell Focus                                 4 (8%)       1 (4%)       3 (6%)                                             
      Eosinophilic Focus                                            5 (19%)      2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05063-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           PHENYLBUTAZONE                                      Date: 09/08/94  
Route: GAVAGE                                                                                                     Time: 19:05:34  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      0.05G/KG     0.1 G/KG                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Fatty Change                                    20 (40%)     11 (41%)     19 (38%)                                            
      Focal Cellular Change                                                      1 (2%)                                             
      Hemorrhage                                       1 (2%)                    1 (2%)                                             
      Hepatodiaphragmatic Nodule                       1 (2%)       3 (11%)      3 (6%)                                             
      Hyperplasia                                      2 (4%)       1 (4%)       2 (4%)                                             
      Inflammation, Chronic Active                    17 (34%)     11 (41%)     10 (20%)                                            
      Mixed Cell Focus                                 2 (4%)                                                                       
      Necrosis, Coagulative                            6 (12%)      3 (11%)      5 (10%)                                            
      Pigmentation                                     1 (2%)                                                                       
      Bile Duct, Cyst                                  1 (2%)                                                                       
      Bile Duct, Hyperplasia                          28 (56%)      8 (30%)     23 (46%)                                            
      Centrilobular, Cytomegaly                                                  1 (2%)                                             
      Kupffer Cell, Hyperplasia, Focal                 1 (2%)                    1 (2%)                                             
      Periportal, Fibrosis                             2 (4%)       1 (4%)       1 (2%)                                             
      Serosa, Inflammation, Chronic, Focal                          1 (4%)                                                          
      Serosa, Inflammation, Suppurative                                          1 (2%)                                             
      Subserosa, Necrosis, Coagulative                                           1 (2%)                                             
   Mesentery                                          (2)          (5)          (10)                                                
      Fibrosis                                         1 (50%)      3 (60%)      2 (20%)                                            
      Hemorrhage                                                    1 (20%)      1 (10%)                                            
      Inflammation, Chronic Active                     1 (50%)                   5 (50%)                                            
      Mineralization                                                2 (40%)      4 (40%)                                            
      Necrosis, Coagulative                            1 (50%)      3 (60%)      5 (50%)                                            
   Pancreas                                           (50)         (9)          (50)                                                
      Atrophy                                         11 (22%)      3 (33%)     11 (22%)                                            
      Fibrosis, Focal                                  1 (2%)                                                                       
      Hyperplasia                                      1 (2%)                                                                       
      Inflammation, Chronic                           12 (24%)      2 (22%)      7 (14%)                                            
   Salivary Glands                                    (50)         (7)          (50)                                                
      Inflammation, Chronic, Focal                     1 (2%)                                                                       
   Stomach, Forestomach                               (49)         (49)         (49)                                                
      Acanthosis                                       4 (8%)                   12 (24%)                                            
      Edema                                                                      1 (2%)                                             
      Erosion                                                                    1 (2%)                                             
      Hyperkeratosis                                   3 (6%)                   12 (24%)                                            
      Hyperplasia, Basal Cell                          4 (8%)       1 (2%)      12 (24%)                                            
      Inflammation, Chronic Active                                               1 (2%)                                             
      Inflammation, Granulomatous                      1 (2%)                                                                       
      Ulcer                                            1 (2%)       1 (2%)      12 (24%)                                            
      Ulcer, Multiple                                  1 (2%)                                                                       
      Muscularis, Mineralization                                    1 (2%)                                                          
      Submucosa, Foreign Body                          1 (2%)                                                                       
   Stomach, Glandular                                 (50)         (49)         (50)                                                
      Abscess                                                                    1 (2%)                                             
      Edema                                                                      1 (2%)                                             
      Erosion                                          2 (4%)       1 (2%)       2 (4%)                                             
      Fibrosis                                                      1 (2%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05063-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           PHENYLBUTAZONE                                      Date: 09/08/94  
Route: GAVAGE                                                                                                     Time: 19:05:34  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      0.05G/KG     0.1 G/KG                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation, Chronic                            1 (2%)                                                                       
      Inflammation, Chronic Active                                               5 (10%)                                            
      Mineralization                                   1 (2%)                    4 (8%)                                             
      Ulcer                                                                      3 (6%)                                             
      Muscularis, Mineralization                                    2 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (2)                                                                           
      Aorta, Inflammation, Chronic Active              1 (50%)                                                                      
   Heart                                              (50)         (7)          (50)                                                
      Cardiomyopathy                                  35 (70%)      4 (57%)     43 (86%)                                            
      Mineralization                                                             3 (6%)                                             
      Necrosis, Focal                                                            1 (2%)                                             
      Atrium, Embolus                                  1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (50)         (50)                                                
      Angiectasis                                     30 (60%)     26 (52%)     17 (34%)                                            
      Atrophy                                          1 (2%)       1 (2%)                                                          
      Autolysis                                        1 (2%)       1 (2%)                                                          
      Congestion                                       1 (2%)                                                                       
      Degeneration                                     1 (2%)                                                                       
      Degeneration, Fatty                                                        1 (2%)                                             
      Hyperplasia                                      7 (14%)     12 (24%)      9 (18%)                                            
      Mineralization                                   1 (2%)                                                                       
      Necrosis, Coagulative                            1 (2%)       2 (4%)       2 (4%)                                             
      Pigmentation                                     1 (2%)                                                                       
      Vacuolization Cytoplasmic                       24 (48%)     27 (54%)     31 (62%)                                            
   Adrenal Gland, Medulla                             (50)         (50)         (50)                                                
      Angiectasis                                                   1 (2%)                                                          
      Autolysis                                        1 (2%)       1 (2%)                                                          
      Hyperplasia                                      3 (6%)       6 (12%)     19 (38%)                                            
      Necrosis, Coagulative                                         2 (4%)                                                          
      Thrombosis                                                                 1 (2%)                                             
   Islets, Pancreatic                                 (50)         (7)          (50)                                                
      Angiectasis, Focal                               1 (2%)                                                                       
      Hyperplasia                                      1 (2%)                                                                       
   Parathyroid Gland                                  (31)         (34)         (14)                                                
      Hyperplasia                                                                3 (21%)                                            
   Pituitary Gland                                    (48)         (49)         (50)                                                
      Pars Distalis, Angiectasis                      36 (75%)     19 (39%)     30 (60%)                                            
      Pars Distalis, Cyst                             23 (48%)     26 (53%)     23 (46%)                                            
      Pars Distalis, Hemorrhage                                     1 (2%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05063-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           PHENYLBUTAZONE                                      Date: 09/08/94  
Route: GAVAGE                                                                                                     Time: 19:05:34  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      0.05G/KG     0.1 G/KG                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Pars Distalis, Hyperplasia                      10 (21%)      6 (12%)     15 (30%)                                            
      Pars Distalis, Pigmentation                     12 (25%)      2 (4%)       6 (12%)                                            
      Pars Intermedia, Angiectasis                     2 (4%)       2 (4%)       1 (2%)                                             
      Pars Intermedia, Cyst                                         4 (8%)                                                          
      Pars Intermedia, Pigmentation                    2 (4%)                                                                       
      Pars Nervosa, Angiectasis                        2 (4%)       1 (2%)                                                          
      Pars Nervosa, Cyst                               1 (2%)                                                                       
      Pars Nervosa, Pigmentation                       1 (2%)                                                                       
   Thyroid Gland                                      (50)         (49)         (50)                                                
      Inflammation, Chronic                            1 (2%)                                                                       
      C-Cell, Hyperplasia                             24 (48%)     26 (53%)     24 (48%)                                            
      Follicular Cell, Cyst                                         1 (2%)                                                          
      Follicular Cell, Hyperplasia                     1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (36)         (11)         (41)                                                
      Inflammation, Acute                                           1 (9%)       3 (7%)                                             
      Inflammation, Chronic                            8 (22%)                   6 (15%)                                            
      Inflammation, Chronic Active                    12 (33%)      1 (9%)      17 (41%)                                            
      Inflammation, Chronic Active, Necrotizing                     4 (36%)                                                         
   Ovary                                              (50)         (14)         (50)                                                
      Atrophy                                                       1 (7%)                                                          
      Congestion                                       1 (2%)                                                                       
      Cyst                                             3 (6%)       2 (14%)      2 (4%)                                             
      Hyperplasia                                                                1 (2%)                                             
      Mineralization                                   2 (4%)                                                                       
      Corpus Luteum, Cyst                              1 (2%)                                                                       
      Periovarian Tissue, Cyst                         4 (8%)       4 (29%)                                                         
   Oviduct                                            (1)                                                                           
      Inflammation, Chronic                            1 (100%)                                                                     
   Uterus                                             (50)         (17)         (50)                                                
      Hydrometra                                       6 (12%)      1 (6%)       9 (18%)                                            
      Inflammation, Acute                              2 (4%)                    1 (2%)                                             
      Thrombosis                                       1 (2%)                                                                       
      Endometrium, Hyperplasia                         9 (18%)      3 (18%)      7 (14%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05063-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           PHENYLBUTAZONE                                      Date: 09/08/94  
Route: GAVAGE                                                                                                     Time: 19:05:34  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      0.05G/KG     0.1 G/KG                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (49)         (6)          (48)                                                
      Myelofibrosis                                    1 (2%)                    1 (2%)                                             
   Lymph Node                                         (50)         (15)         (49)                                                
      Mediastinal, Depletion Lymphoid                               1 (7%)       1 (2%)                                             
      Mediastinal, Ectasia                                          1 (7%)                                                          
      Mediastinal, Hemorrhage                          3 (6%)       3 (20%)     11 (22%)                                            
      Mediastinal, Hyperplasia                         2 (4%)                                                                       
      Mediastinal, Inflammation, Chronic Active                                  1 (2%)                                             
      Mediastinal, Pigmentation                        4 (8%)                                                                       
      Pancreatic, Depletion Lymphoid                   1 (2%)                                                                       
      Pancreatic, Infiltration Cellular, Histiocyte    1 (2%)                                                                       
      Pancreatic, Pigmentation                         3 (6%)                                                                       
      Renal, Angiectasis                               1 (2%)                                                                       
      Renal, Ectasia                                                             1 (2%)                                             
      Renal, Hemorrhage                                1 (2%)                                                                       
      Renal, Hyperplasia                                            1 (7%)                                                          
      Renal, Infiltration Cellular, Histiocyte                                   1 (2%)                                             
      Renal, Pigmentation                                                        1 (2%)                                             
   Lymph Node, Mandibular                             (42)         (5)          (37)                                                
      Angiectasis                                      1 (2%)                                                                       
      Depletion Lymphoid                                                         1 (3%)                                             
      Ectasia                                          4 (10%)                   1 (3%)                                             
      Hemorrhage                                       6 (14%)      2 (40%)      7 (19%)                                            
      Hyperplasia                                      1 (2%)                    5 (14%)                                            
      Infiltration Cellular, Histiocyte                                          1 (3%)                                             
      Pigmentation                                     1 (2%)                    1 (3%)                                             
   Lymph Node, Mesenteric                             (50)         (13)         (46)                                                
      Depletion Lymphoid                                            1 (8%)       2 (4%)                                             
      Ectasia                                                                    5 (11%)                                            
      Hemorrhage                                       2 (4%)                    4 (9%)                                             
      Hyperplasia                                                                1 (2%)                                             
      Infiltration Cellular, Histiocyte               35 (70%)      5 (38%)     28 (61%)                                            
      Pigmentation                                    34 (68%)      7 (54%)     29 (63%)                                            
   Spleen                                             (50)         (50)         (50)                                                
      Congestion                                       2 (4%)       1 (2%)                                                          
      Depletion Lymphoid                              14 (28%)     14 (28%)     19 (38%)                                            
      Hematopoietic Cell Proliferation                 1 (2%)                    4 (8%)                                             
      Pigmentation                                     4 (8%)       5 (10%)      1 (2%)                                             
      Capsule, Fibrosis, Focal                         1 (2%)                                                                       
      Subcapsular, Necrosis, Coagulative                                         1 (2%)                                             
   Thymus                                             (42)         (8)          (38)                                                
      Congestion                                                    1 (13%)      2 (5%)                                             
      Cyst                                                                       2 (5%)                                             
      Depletion Lymphoid                              28 (67%)      6 (75%)     32 (84%)                                            
      Hemorrhage                                       2 (5%)       2 (25%)                                                         
      Necrosis                                         1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05063-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           PHENYLBUTAZONE                                      Date: 09/08/94  
Route: GAVAGE                                                                                                     Time: 19:05:34  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      0.05G/KG     0.1 G/KG                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (46)         (18)         (40)                                                
      Degeneration                                                               1 (3%)                                             
      Galactocele                                      4 (9%)       1 (6%)       1 (3%)                                             
      Hyperplasia                                     41 (89%)      5 (28%)     32 (80%)                                            
      Inflammation, Chronic Active                     1 (2%)                                                                       
   Skin                                               (50)         (12)         (49)                                                
      Subcutaneous Tissue, Inflammation, Chronic                                                                                    
          Active, Granulomatous                                     1 (8%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (49)         (7)          (50)                                                
      Fibrous Osteodystrophy                                                     1 (2%)                                             
      Hyperostosis                                                               1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (10)         (50)                                                
      Congestion                                                                 1 (2%)                                             
      Hemorrhage                                       2 (4%)                                                                       
      Hydrocephalus                                    1 (2%)                                                                       
      Cerebellum, Infarct                              2 (4%)                                                                       
      Medulla, Infarct                                 1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (20)         (50)                                                
      Congestion                                       1 (2%)       3 (15%)      2 (4%)                                             
      Edema                                                                      2 (4%)                                             
      Foreign Body                                                               4 (8%)                                             
      Granuloma                                                                  1 (2%)                                             
      Hemorrhage                                       4 (8%)       1 (5%)                                                          
      Infiltration Cellular, Histiocyte                9 (18%)      6 (30%)     22 (44%)                                            
      Inflammation, Acute                                                        3 (6%)                                             
      Inflammation, Acute, Necrotizing                 1 (2%)                    1 (2%)                                             
      Inflammation, Chronic                           11 (22%)                   8 (16%)                                            
      Inflammation, Chronic Active                     9 (18%)      4 (20%)      6 (12%)                                            
      Thrombosis, Multiple                                                       1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 9 (18%)      1 (5%)       2 (4%)                                             
      Artery, Hyperplasia                              1 (2%)                                                                       
      Artery, Mineralization                          18 (36%)      4 (20%)     19 (38%)                                            
      Bronchus, Mineralization                                                   1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05063-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           PHENYLBUTAZONE                                      Date: 09/08/94  
Route: GAVAGE                                                                                                     Time: 19:05:34  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      0.05G/KG     0.1 G/KG                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
   Nose                                               (48)         (6)          (49)                                                
      Inflammation, Acute                              4 (8%)                    3 (6%)                                             
      Inflammation, Acute, Necrotizing                                           1 (2%)                                             
      Inflammation, Chronic                                                      1 (2%)                                             
      Inflammation, Chronic Active                     5 (10%)                   1 (2%)                                             
      Inflammation, Chronic Active, Necrotizing        1 (2%)                                                                       
      Nasolacrimal Duct, Inflammation, Chronic         1 (2%)       1 (17%)      3 (6%)                                             
      Nasolacrimal Duct, Inflammation, Chronic                                                                                      
          Active                                       1 (2%)                    1 (2%)                                             
      Nasolacrimal Duct, Metaplasia, Squamous                       1 (17%)      1 (2%)                                             
   Trachea                                            (50)         (48)         (50)                                                
      Inflammation, Acute, Necrotizing                                           1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (3)                                                                           
      Cataract                                         1 (33%)                                                                      
      Retina, Degeneration                             1 (33%)                                                                      
      Sclera, Metaplasia, Osseous                      1 (33%)                                                                      
   Harderian Gland                                    (2)                                                                           
      Hyperplasia                                      1 (50%)                                                                      
      Inflammation, Chronic                            1 (50%)                                                                      
   Lacrimal Gland                                                               (1)                                                 
      Hyperplasia                                                                1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)                                                
      Atrophy                                          1 (2%)                                                                       
      Bacterium                                                                  3 (6%)                                             
      Cyst                                             1 (2%)       2 (4%)      16 (32%)                                            
      Inflammation, Acute, Necrotizing                              1 (2%)       2 (4%)                                             
      Inflammation, Chronic Active                                               1 (2%)                                             
      Inflammation, Chronic Active, Necrotizing                                  2 (4%)                                             
      Nephropathy                                     38 (76%)     46 (92%)     47 (94%)                                            
      Pigmentation                                     2 (4%)                    1 (2%)                                             
      Collecting Tubule, Mineralization                3 (6%)      31 (62%)     46 (92%)                                            
      Distal Convoluted Renal Tubule,                                                                                               
          Mineralization                               1 (2%)                                                                       
      Papilla, Angiectasis                                                       4 (8%)                                             
      Papilla, Inflammation, Acute                                               2 (4%)                                             
      Papilla, Mineralization                                       1 (2%)                                                          
      Papilla, Necrosis                                            18 (36%)     35 (70%)                                            
      Papilla, Necrosis, Coagulative                                             6 (12%)                                            
      Pelvis, Calculus Gross Observation                                         1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05063-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           PHENYLBUTAZONE                                      Date: 09/08/94  
Route: GAVAGE                                                                                                     Time: 19:05:34  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   VEHICLE      0.05G/KG     0.1 G/KG                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Pelvis, Dilatation                               1 (2%)                   22 (44%)                                            
      Pelvis, Epithelium, Hyperplasia                  7 (14%)     20 (40%)     37 (74%)                                            
      Pelvis, Epithelium, Mineralization              13 (26%)     11 (22%)      6 (12%)                                            
      Proximal Convoluted Renal Tubule, Hyperplasia                              1 (2%)                                             
      Proximal Convoluted Renal Tubule,                                                                                             
          Inflammation, Acute                          2 (4%)       4 (8%)      26 (52%)                                            
      Proximal Convoluted Renal Tubule,                                                                                             
          Mineralization                               1 (2%)                    4 (8%)                                             
      Proximal Convoluted Renal Tubule,                                                                                             
          Pigmentation                                 4 (8%)       1 (2%)       1 (2%)                                             
      Renal Tubule, Hyperplasia                        1 (2%)       1 (2%)       1 (2%)                                             
   Ureter                                                                       (1)                                                 
      Dilatation                                                                 1 (100%)                                           
   Urinary Bladder                                    (50)         (49)         (49)                                                
      Calculus Gross Observation                       1 (2%)                                                                       
      Inflammation, Acute, Focal, Necrotizing                                    1 (2%)                                             
      Inflammation, Acute, Necrotizing                              1 (2%)                                                          
      Inflammation, Chronic                            1 (2%)       1 (2%)       1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)                                             
      Metaplasia, Squamous                             1 (2%)                                                                       
      Transitional Epithelium, Hyperplasia             1 (2%)                    3 (6%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05063-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           PHENYLBUTAZONE                                      Date: 09/08/94  
Route: GAVAGE                                                                                                     Time: 19:05:34  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      0.05G/KG     0.1 G/KG                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50                                                  
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                11           13           16                                                  
    Natural Death                                      6           16            7                                                  
    Accident                                                        1                                                               
  Survivors                                                                                                                         
    Terminal Sacrifice                                32           20           27                                                  
    Terminal Sacrifice                                 1                                                                            
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (44)         (17)         (32)                                                
      Inflammation, Acute, Necrotizing                                           1 (3%)                                             
      Submucosa, Hemorrhage                            1 (2%)                                                                       
   Intestine Large, Cecum                             (47)         (14)         (50)                                                
      Inflammation, Acute, Necrotizing                                           1 (2%)                                             
      Parasite Metazoan                                1 (2%)                    2 (4%)                                             
   Intestine Large, Colon                             (50)         (21)         (49)                                                
      Angiectasis                                      1 (2%)                                                                       
      Parasite Metazoan                               13 (26%)      3 (14%)     12 (24%)                                            
   Intestine Large, Rectum                            (49)         (18)         (49)                                                
      Parasite Metazoan                                2 (4%)                    2 (4%)                                             
   Intestine Small, Duodenum                          (50)         (23)         (49)                                                
      Inflammation, Acute, Necrotizing                                           1 (2%)                                             
      Inflammation, Chronic Active                                               1 (2%)                                             
      Epithelium, Hyperplasia                                                    1 (2%)                                             
   Liver                                              (50)         (50)         (50)                                                
      Angiectasis                                                   2 (4%)       2 (4%)                                             
      Basophilic Focus                                37 (74%)     27 (54%)     25 (50%)                                            
      Clear Cell Focus                                15 (30%)     11 (22%)     19 (38%)                                            
      Congestion                                                    1 (2%)                                                          
      Degeneration, Cystic                             4 (8%)       1 (2%)       4 (8%)                                             
      Eosinophilic Focus                               7 (14%)      9 (18%)     10 (20%)                                            
      Fatty Change                                    41 (82%)     39 (78%)     49 (98%)                                            
      Fibrosis                                         1 (2%)                                                                       
      Hemorrhage                                       1 (2%)       1 (2%)                                                          
      Hepatodiaphragmatic Nodule                                    2 (4%)       1 (2%)                                             
      Hyperplasia                                                                3 (6%)                                             
      Infarct                                                       1 (2%)                                                          
      Inflammation, Chronic Active                    28 (56%)     23 (46%)     17 (34%)                                            
      Mixed Cell Focus                                 3 (6%)       4 (8%)       7 (14%)                                            
      Necrosis, Coagulative                            6 (12%)      6 (12%)      5 (10%)                                            
      Bile Duct, Hyperplasia                          35 (70%)     43 (86%)     32 (64%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05063-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           PHENYLBUTAZONE                                      Date: 09/08/94  
Route: GAVAGE                                                                                                     Time: 19:05:34  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      0.05G/KG     0.1 G/KG                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Centrilobular, Cytomegaly                                                  1 (2%)                                             
      Kupffer Cell, Hyperplasia                                     2 (4%)                                                          
   Mesentery                                          (4)          (5)          (3)                                                 
      Inflammation, Chronic Active                     1 (25%)      2 (40%)                                                         
      Necrosis, Coagulative                            1 (25%)      2 (40%)      1 (33%)                                            
   Pancreas                                           (50)         (27)         (50)                                                
      Atrophy                                          9 (18%)      2 (7%)      15 (30%)                                            
      Ectopic Tissue                                   1 (2%)                                                                       
      Hyperplasia                                      8 (16%)      3 (11%)      6 (12%)                                            
      Inflammation, Chronic                            8 (16%)      1 (4%)       6 (12%)                                            
      Inflammation, Chronic Active                                  1 (4%)                                                          
      Pigmentation                                     2 (4%)                                                                       
      Acinus, Hyperplasia                              1 (2%)                                                                       
      Duct, Hyperplasia                                1 (2%)                                                                       
   Salivary Glands                                    (49)         (23)         (49)                                                
      Atrophy                                                                    1 (2%)                                             
      Hemorrhage                                       2 (4%)                                                                       
      Inflammation, Chronic                            2 (4%)       1 (4%)       1 (2%)                                             
      Parotid Gland, Atrophy                                                     1 (2%)                                             
      Submandibular Gland, Atrophy                                               1 (2%)                                             
   Stomach, Forestomach                               (50)         (50)         (50)                                                
      Acanthosis                                       4 (8%)       8 (16%)      7 (14%)                                            
      Hyperkeratosis                                   3 (6%)       8 (16%)      7 (14%)                                            
      Hyperplasia, Basal Cell                          4 (8%)       9 (18%)      2 (4%)                                             
      Hyperplasia, Pseudoepitheliomatous                            1 (2%)                                                          
      Inflammation, Chronic Active                                  3 (6%)       2 (4%)                                             
      Ulcer                                                         5 (10%)      6 (12%)                                            
      Muscularis, Mineralization                       1 (2%)                                                                       
   Stomach, Glandular                                 (50)         (50)         (49)                                                
      Erosion                                                       1 (2%)       2 (4%)                                             
      Fibrosis                                         1 (2%)                                                                       
      Inflammation, Chronic                                         1 (2%)                                                          
      Inflammation, Chronic Active                                               6 (12%)                                            
      Mineralization                                   1 (2%)       1 (2%)       1 (2%)                                             
      Ulcer                                            1 (2%)                    1 (2%)                                             
      Arteriole, Mineralization                        1 (2%)                                                                       
      Epithelium, Hyperplasia                                                    1 (2%)                                             
      Mucosa, Mineralization                                        1 (2%)                                                          
      Mucosa, Necrosis                                              1 (2%)                                                          
      Muscularis, Mineralization                       2 (4%)       3 (6%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05063-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           PHENYLBUTAZONE                                      Date: 09/08/94  
Route: GAVAGE                                                                                                     Time: 19:05:34  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      0.05G/KG     0.1 G/KG                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (20)         (50)                                                
      Cardiomyopathy                                  48 (96%)     18 (90%)     48 (96%)                                            
      Atrioventricular Valve, Mineralization, Focal    1 (2%)                                                                       
      Atrium, Congestion                                                         1 (2%)                                             
      Atrium, Thrombosis                               1 (2%)       1 (5%)       3 (6%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (49)         (50)                                                
      Angiectasis                                     29 (58%)     19 (39%)     18 (36%)                                            
      Atrophy                                          1 (2%)                                                                       
      Congestion                                                    1 (2%)                                                          
      Hyperplasia                                      7 (14%)      6 (12%)      9 (18%)                                            
      Vacuolization Cytoplasmic                       32 (64%)     26 (53%)     32 (64%)                                            
   Adrenal Gland, Medulla                             (50)         (48)         (49)                                                
      Angiectasis                                     34 (68%)     23 (48%)     23 (47%)                                            
      Fibrosis                                         1 (2%)                                                                       
      Hyperplasia                                     11 (22%)     15 (31%)     12 (24%)                                            
      Mineralization                                   1 (2%)                                                                       
      Necrosis                                         1 (2%)                                                                       
      Thrombosis                                       2 (4%)                                                                       
   Islets, Pancreatic                                 (50)         (22)         (50)                                                
      Hyperplasia                                      2 (4%)                    2 (4%)                                             
   Pituitary Gland                                    (48)         (26)         (47)                                                
      Pars Distalis, Angiectasis                       4 (8%)       1 (4%)       1 (2%)                                             
      Pars Distalis, Cyst                              2 (4%)       1 (4%)       2 (4%)                                             
      Pars Distalis, Hemorrhage                        1 (2%)                                                                       
      Pars Distalis, Hyperplasia                      22 (46%)      8 (31%)     26 (55%)                                            
      Pars Distalis, Necrosis, Coagulative             1 (2%)                                                                       
      Pars Distalis, Pigmentation                                   2 (8%)                                                          
      Pars Intermedia, Angiectasis                     2 (4%)                    1 (2%)                                             
      Pars Intermedia, Cyst                            1 (2%)                    1 (2%)                                             
      Pars Intermedia, Hyperplasia                                               1 (2%)                                             
      Pars Intermedia, Pigmentation                                 1 (4%)                                                          
   Thyroid Gland                                      (49)         (21)         (49)                                                
      C-Cell, Hyperplasia                             22 (45%)      3 (14%)     17 (35%)                                            
      Follicle, Cyst                                   1 (2%)                    1 (2%)                                             
      Follicle, Mineralization                         1 (2%)                                                                       
      Follicular Cell, Hyperplasia                     1 (2%)                    2 (4%)                                             
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05063-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           PHENYLBUTAZONE                                      Date: 09/08/94  
Route: GAVAGE                                                                                                     Time: 19:05:34  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      0.05G/KG     0.1 G/KG                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (49)         (50)                                                
      Hyperplasia                                                   1 (2%)                                                          
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Epithelium, Hyperplasia                         16 (32%)     26 (53%)     26 (52%)                                            
   Preputial Gland                                    (43)         (25)         (47)                                                
      Abscess                                                       1 (4%)                                                          
      Fibrosis                                         1 (2%)                                                                       
      Hyperplasia                                                                1 (2%)                                             
      Inflammation, Acute                              1 (2%)                    2 (4%)                                             
      Inflammation, Chronic                           16 (37%)      7 (28%)      7 (15%)                                            
      Inflammation, Chronic Active                    22 (51%)     12 (48%)     36 (77%)                                            
   Prostate                                           (50)         (21)         (46)                                                
      Atrophy                                          1 (2%)                                                                       
      Cyst                                                                       1 (2%)                                             
      Inflammation, Acute                              5 (10%)      3 (14%)      9 (20%)                                            
      Inflammation, Chronic                                                      4 (9%)                                             
      Inflammation, Chronic Active                    19 (38%)      5 (24%)     10 (22%)                                            
      Epithelium, Hyperplasia                          4 (8%)                                                                       
   Seminal Vesicle                                    (49)         (36)         (47)                                                
      Atrophy                                         17 (35%)     14 (39%)     23 (49%)                                            
      Inflammation, Acute                                           1 (3%)                                                          
   Testes                                             (50)         (49)         (50)                                                
      Hemorrhage                                                                 1 (2%)                                             
      Arteriole, Inflammation, Chronic Active          2 (4%)                                                                       
      Arteriole, Necrosis, Fibrinoid                   1 (2%)                                                                       
      Interstitial Cell, Hyperplasia                  35 (70%)     14 (29%)     29 (58%)                                            
      Seminiferous Tubule, Atrophy                    44 (88%)     41 (84%)     45 (90%)                                            
      Seminiferous Tubule, Mineralization              5 (10%)     26 (53%)     14 (28%)                                            
      Seminiferous Tubule, Necrosis, Coagulative       1 (2%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node                                         (50)         (26)         (50)                                                
      Mediastinal, Angiectasis                         2 (4%)                                                                       
      Mediastinal, Depletion Lymphoid                               1 (4%)       1 (2%)                                             
      Mediastinal, Ectasia                             1 (2%)       1 (4%)                                                          
      Mediastinal, Hemorrhage                          8 (16%)      1 (4%)       7 (14%)                                            
      Mediastinal, Hyperplasia                         1 (2%)                                                                       
      Mediastinal, Inflammation, Chronic Active                     1 (4%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
NTP Experiment-Test: 05063-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           PHENYLBUTAZONE                                      Date: 09/08/94  
Route: GAVAGE                                                                                                     Time: 19:05:34  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      0.05G/KG     0.1 G/KG                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Mediastinal, Pigmentation                        3 (6%)       2 (8%)       3 (6%)                                             
      Pancreatic, Angiectasis                          1 (2%)                                                                       
      Pancreatic, Fibrosis                             1 (2%)                                                                       
      Pancreatic, Hemorrhage                                        1 (4%)                                                          
      Pancreatic, Infiltration Cellular, Histiocyte                 1 (4%)                                                          
      Pancreatic, Pigmentation                         1 (2%)                                                                       
      Renal, Hemorrhage                                             1 (4%)                                                          
      Renal, Pigmentation                              1 (2%)       1 (4%)                                                          
   Lymph Node, Mandibular                             (44)         (18)         (41)                                                
      Angiectasis                                      1 (2%)                                                                       
      Congestion                                       1 (2%)                    1 (2%)                                             
      Ectasia                                         10 (23%)      1 (6%)       2 (5%)                                             
      Hematocyst                                                                 1 (2%)                                             
      Hemorrhage                                       5 (11%)      3 (17%)      5 (12%)                                            
      Hyperplasia                                      7 (16%)      1 (6%)       2 (5%)                                             
      Infiltration Cellular, Histiocyte                                          3 (7%)                                             
      Pigmentation                                                               2 (5%)                                             
   Lymph Node, Mesenteric                             (47)         (19)         (49)                                                
      Angiectasis                                      1 (2%)                    1 (2%)                                             
      Hemorrhage                                       1 (2%)       1 (5%)       5 (10%)                                            
      Infiltration Cellular, Histiocyte               30 (64%)      3 (16%)     35 (71%)                                            
      Pigmentation                                    34 (72%)      4 (21%)     32 (65%)                                            
   Spleen                                             (50)         (32)         (50)                                                
      Congestion                                       2 (4%)       1 (3%)       1 (2%)                                             
      Depletion Lymphoid                               6 (12%)     13 (41%)      9 (18%)                                            
      Fibrosis                                         2 (4%)       2 (6%)                                                          
      Hematopoietic Cell Proliferation                 1 (2%)       1 (3%)       3 (6%)                                             
      Hyperplasia, Reticulum Cell                                                4 (8%)                                             
      Necrosis, Coagulative, Focal                     1 (2%)                                                                       
      Pigmentation                                                  1 (3%)                                                          
      Capsule, Inflammation, Chronic Active,                                                                                        
          Necrotizing                                               1 (3%)                                                          
   Thymus                                             (42)         (18)         (42)                                                
      Congestion                                                    1 (6%)                                                          
      Cyst                                             2 (5%)                    1 (2%)                                             
      Depletion Lymphoid                              37 (88%)     13 (72%)     38 (90%)                                            
      Hemorrhage                                       1 (2%)       2 (11%)      1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (21)         (8)          (24)                                                
      Galactocele                                                   1 (13%)                                                         
      Hyperplasia                                     10 (48%)      3 (38%)     19 (79%)                                            
      Pigmentation                                     1 (5%)                                                                       
   Skin                                               (50)         (27)         (49)                                                
      Acanthosis                                       1 (2%)       2 (7%)       2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   14                                                              
NTP Experiment-Test: 05063-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           PHENYLBUTAZONE                                      Date: 09/08/94  
Route: GAVAGE                                                                                                     Time: 19:05:34  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      0.05G/KG     0.1 G/KG                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
      Atrophy                                          1 (2%)                                                                       
      Cyst Epithelial Inclusion                        2 (4%)                    1 (2%)                                             
      Hyperkeratosis                                   1 (2%)       1 (4%)       2 (4%)                                             
      Hyperplasia, Basal Cell                          1 (2%)                    2 (4%)                                             
      Hyperplasia, Pseudoepitheliomatous                            1 (4%)                                                          
      Inflammation, Acute, Hemorrhagic                              1 (4%)                                                          
      Inflammation, Acute, Necrotizing                              1 (4%)                                                          
      Inflammation, Chronic Active                                  1 (4%)       1 (2%)                                             
      Inflammation, Chronic Active, Necrotizing        2 (4%)                                                                       
      Ulcer                                                                      1 (2%)                                             
      Subcutaneous Tissue, Fibrosis                    2 (4%)       1 (4%)                                                          
      Subcutaneous Tissue, Inflammation, Chronic                                                                                    
          Active                                                    1 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (21)         (50)                                                
      Autolysis                                                     1 (5%)                                                          
   Skeletal Muscle                                    (1)          (3)          (1)                                                 
      Hemorrhage                                                    1 (33%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (20)         (50)                                                
      Mineralization, Multifocal                       1 (2%)                                                                       
      Pigmentation                                     1 (2%)                                                                       
      Meninges, Hemorrhage                             1 (2%)                    1 (2%)                                             
      Thalamus, Mineralization                                                   1 (2%)                                             
      Third Ventricle, Hemorrhage                                   1 (5%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (34)         (50)                                                
      Congestion                                       2 (4%)      10 (29%)      4 (8%)                                             
      Crystals                                                      1 (3%)       1 (2%)                                             
      Edema                                                         2 (6%)       1 (2%)                                             
      Fibrosis                                         2 (4%)       1 (3%)                                                          
      Foreign Body                                     1 (2%)                                                                       
      Granuloma                                        1 (2%)       1 (3%)       2 (4%)                                             
      Hemorrhage                                       2 (4%)       2 (6%)       1 (2%)                                             
      Infiltration Cellular, Histiocyte               13 (26%)     13 (38%)     12 (24%)                                            
      Inflammation, Chronic                           11 (22%)      4 (12%)      2 (4%)                                             
      Inflammation, Chronic Active                     7 (14%)      3 (9%)       6 (12%)                                            
      Metaplasia, Focal, Osseous                                                 1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   15                                                              
NTP Experiment-Test: 05063-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           PHENYLBUTAZONE                                      Date: 09/08/94  
Route: GAVAGE                                                                                                     Time: 19:05:34  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      0.05G/KG     0.1 G/KG                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Pigmentation                                                               1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 7 (14%)      3 (9%)       5 (10%)                                            
      Artery, Hyperplasia                              2 (4%)       1 (3%)       1 (2%)                                             
      Artery, Mineralization                          21 (42%)     16 (47%)     24 (48%)                                            
      Bronchiole, Epithelium, Hyperplasia              1 (2%)                    1 (2%)                                             
      Bronchus, Bronchiectasis                                      1 (3%)                                                          
   Nose                                               (49)         (19)         (49)                                                
      Edema                                                         2 (11%)                                                         
      Hemorrhage                                       2 (4%)       1 (5%)       2 (4%)                                             
      Inflammation, Acute                             11 (22%)                   5 (10%)                                            
      Inflammation, Chronic                            2 (4%)                    1 (2%)                                             
      Inflammation, Chronic Active                     4 (8%)       1 (5%)       2 (4%)                                             
      Nasolacrimal Duct, Inflammation, Acute           1 (2%)                    1 (2%)                                             
      Nasolacrimal Duct, Inflammation, Chronic         1 (2%)       3 (16%)      2 (4%)                                             
      Nasolacrimal Duct, Inflammation, Chronic                                                                                      
          Active                                                    1 (5%)                                                          
      Nasolacrimal Duct, Metaplasia, Squamous                       2 (11%)      4 (8%)                                             
      Nasopharyngeal Duct, Inflammation, Chronic                                                                                    
          Active                                       1 (2%)                                                                       
   Trachea                                            (50)         (21)         (50)                                                
      Inflammation, Acute, Necrotizing                                           1 (2%)                                             
      Peritracheal Tissue, Hemorrhage                  1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                (3)          (1)                                                              
      Inflammation, Chronic Active                     1 (33%)      1 (100%)                                                        
   Eye                                                (1)                       (3)                                                 
      Cataract                                                                   1 (33%)                                            
      Retina, Degeneration                                                       1 (33%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (49)         (50)                                                
      Congestion                                       3 (6%)                    8 (16%)                                            
      Cyst                                             2 (4%)                    2 (4%)                                             
      Metaplasia, Osseous                                           1 (2%)                                                          
      Nephropathy                                     49 (98%)     49 (100%)    50 (100%)                                           
      Collecting Tubule, Mineralization                5 (10%)     10 (20%)     35 (70%)                                            
      Papilla, Necrosis                                1 (2%)      10 (20%)     24 (48%)                                            
      Papilla, Necrosis, Coagulative                                             1 (2%)                                             
      Pelvis, Dilatation                               1 (2%)       1 (2%)       1 (2%)                                             
      Pelvis, Mineralization                           1 (2%)                                                                       
      Pelvis, Epithelium, Hyperplasia                 14 (28%)      7 (14%)     12 (24%)                                            
      Proximal Convoluted Renal Tubule,                                                                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   16                                                              
NTP Experiment-Test: 05063-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           PHENYLBUTAZONE                                      Date: 09/08/94  
Route: GAVAGE                                                                                                     Time: 19:05:34  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     VEHICLE      0.05G/KG     0.1 G/KG                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
          Inflammation, Acute                          6 (12%)     13 (27%)     27 (54%)                                            
      Proximal Convoluted Renal Tubule,                                                                                             
          Mineralization                               1 (2%)       1 (2%)                                                          
      Proximal Convoluted Renal Tubule,                                                                                             
          Pigmentation                                 2 (4%)       1 (2%)       1 (2%)                                             
      Renal Tubule, Hyperplasia                        3 (6%)       1 (2%)       3 (6%)                                             
      Renal Tubule, Hyperplasia, Focal                                           1 (2%)                                             
   Urethra                                            (1)          (1)          (1)                                                 
      Calculus Micro Observation Only                  1 (100%)     1 (100%)     1 (100%)                                           
   Urinary Bladder                                    (45)         (22)         (48)                                                
      Calculus Micro Observation Only                               1 (5%)                                                          
      Hemorrhage                                       1 (2%)                                                                       
      Inflammation, Chronic                            2 (4%)       1 (5%)                                                          
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   17                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------